David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Matsons
MATX
$6.63B
| $2.34M | ﹤0.01% |
58,246
-86,408
| -60% | -$3.38M |
|
1752
PUT
Skyworks Solutions
SWKS
$10B
| $2.34M | ﹤0.01% |
30,000
-147,700
| -83% | -$10M |
|
1753
CALL
W.W. Grainger
GWW
$62.9B
| $2.33M | ﹤0.01% |
10,000
-8,000
| -44% | -$1.68M |
|
1754
CALL
Travelers Companies
TRV
$77.4B
| $2.33M | ﹤0.01% |
20,000
-10,000
| -33% | -$1.09M |
|
1755
Iron Mountain
IRM
$36.2B
| $2.32M | ﹤0.01% |
68,400
+34,139
| +100% | +$981K |
|
1756
News Corp Class B
NWS
$18.9B
| $2.32M | ﹤0.01% |
174,976
-673,757
| -79% | -$8.34M |
|
|
ELP
1757
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $2.32M | ﹤0.01% |
731,793
+253,368
| +53% | +$621K |
|
|
EVDY
1758
DELISTED
Everyday Health, Inc.
EVDY
| $2.32M | ﹤0.01% |
413,784
+237,320
| +134% | +$1.17M |
|
1759
PUT
Ross Stores
ROST
$75.8B
| $2.32M | ﹤0.01% |
40,000
-180,600
| -82% | -$10M |
|
|
VSA
1760
VisionSys AI
VSA
$9.66M
| $2.3M | ﹤0.01% |
85
+23
| +37% | +$562K |
|
1761
CALL
Bristol-Myers Squibb
BMY
$138B
| $2.3M | ﹤0.01% |
36,000
-60,300
| -63% | -$3.8M |
|
1762
PUT
Murphy Oil
MUR
$4.97B
| $2.3M | ﹤0.01% |
91,300
+21,900
| +32% | +$439K |
|
|
BFX
1763
DELISTED
BowFlex Inc.
BFX
| $2.3M | ﹤0.01% |
119,073
-117,222
| -50% | -$2.2M |
|
|
AVNS
1764
DELISTED
Avanos Medical
AVNS
| $2.3M | ﹤0.01% |
80,024
-130,477
| -62% | -$3.48M |
|
1765
Vishay Precision Group
VPG
$853M
| $2.28M | ﹤0.01% |
162,809
+45,865
| +39% | +$538K |
|
1766
CALL
Howard Hughes
HHH
$3.92B
| $2.28M | ﹤0.01% |
+22,554
| New | +$2.07M |
|
1767
Insight Enterprises
NSIT
$4.46B
| $2.28M | ﹤0.01% |
79,512
+9,745
| +14% | +$245K |
|
|
EIGI
1768
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $2.27M | ﹤0.01% |
+215,995
| New | +$2.14M |
|
1769
Haemonetics
HAE
$4.85B
| $2.27M | ﹤0.01% |
64,992
+52,460
| +419% | +$1.69M |
|
1770
B2Gold
BTG
$7.58B
| $2.27M | ﹤0.01% |
1,368,755
-1,465,341
| -52% | -$1.6M |
|
1771
M/I Homes
MHO
$3.85B
| $2.27M | ﹤0.01% |
121,599
+19,287
| +19% | +$347K |
|
|
DFRG
1772
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $2.26M | ﹤0.01% |
136,476
+86,535
| +173% | +$1.36M |
|
1773
iShares MSCI Australia ETF
EWA
$1.34B
| $2.26M | ﹤0.01% |
116,750
| – | – |
|
|
MYCC
1774
PUT
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $2.25M | ﹤0.01% |
+160,000
| New | +$2.11M |
|
|
PBPB
1775
DELISTED
Potbelly
PBPB
| $2.24M | ﹤0.01% |
164,771
+85,421
| +108% | +$1.02M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.